β-Lactamase inhibitors to restore the efficacy of antibiotics against superbugs

C Gonzalez-Bello, D Rodríguez, M Pernas… - Journal of medicinal …, 2019 - ACS Publications
Infections caused by resistant bacteria are nowadays too common, and some pathogens
have even become resistant to multiple types of antibiotics, in which case few or even no …

[HTML][HTML] Novel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistance

RR Watkins, KM Papp-Wallace, SM Drawz… - Frontiers in …, 2013 - frontiersin.org
The increasing incidence and prevalence of multi-drug resistance (MDR) among
contemporary Gram-negative bacteria represents a significant threat to human health. Since …

β-Lactamase inhibitors: the story so far

FJ Perez-Llarena, G Bou - Current medicinal chemistry, 2009 - ingentaconnect.com
Antimicrobial resistance constitutes one of the major threats regarding pathogenic
microorganisms. Gramnegative pathogens, such as Enterobacteriaceae (specially those …

New (and not so new) antibacterial targets–from where and when will the novel drugs come?

SJ Projan - Current opinion in pharmacology, 2002 - Elsevier
Although the need for new antibacterial therapies and strategies is greater than it has been
in a quarter of a century and despite considerable effort, little progress has been observed in …

Game changers: new β-lactamase inhibitor combinations targeting antibiotic resistance in Gram-negative bacteria

K Bush - ACS infectious Diseases, 2018 - ACS Publications
Recent regulatory approvals for the β-lactam inhibitor combinations of ceftazidime–
avibactam and meropenem–vaborbactam have provided two novel therapeutic options for …

[HTML][HTML] β-Lactam potentiators to re-sensitize resistant pathogens: Discovery, development, clinical use and the way forward

L Narendrakumar, M Chakraborty, S Kumari… - Frontiers in …, 2023 - frontiersin.org
β-lactam antibiotics are one of the most widely used and diverse classes of antimicrobial
agents for treating both Gram-negative and Gram-positive bacterial infections. The β-lactam …

An update on β-lactamase inhibitor discovery and development

JD Docquier, S Mangani - Drug Resistance Updates, 2018 - Elsevier
Antibiotic resistance, and the emergence of pan-resistant clinical isolates, seriously
threatens our capability to treat bacterial diseases, including potentially deadly hospital …

New β-lactam antibiotics and β-lactamase inhibitors

K Bush, MJ Macielag - Expert opinion on therapeutic patents, 2010 - Taylor & Francis
Importance of the field: β-Lactam antibiotics are among the most frequently prescribed
antibiotics used to treat bacterial infections. However, their utility is being threatened by the …

β-lactam antibiotics: An overview from a medicinal chemistry perspective

LM Lima, BNM da Silva, G Barbosa… - European journal of …, 2020 - Elsevier
Abstract β-Lactam antibiotics are one of the most relevant drug classes of antibacterial
agents worldwide. The discovery and the market of first β-lactam antibiotic (Penicillin G) is a …

[HTML][HTML] New antibiotics for bad bugs: where are we?

M Bassetti, M Merelli, C Temperoni… - Annals of clinical …, 2013 - Springer
Bacterial resistance to antibiotics is growing up day by day in both community and hospital
setting, with a significant impact on the mortality and morbidity rates and the financial burden …